Bibliography
- Rayavarapu RG , PetersenW, UngureanuC, PostJN, Van Leeuwen TG, Manohar S: Synthesis and bioconjugation of gold nanoparticles as potential molecular probes for light-based imaging techniques. Int. J. Biomed Imaging29817 (2007).
- De Jong WH , BormPJA: Drug delivery and nanoparticles: applications and hazards.Int. J. Nanomedicine3, 133–149 (2008).
- Duncan R : The dawning era of polymer therapeutics.Nat. Rev. Drug Disc.2, 347–360 (2003).
- Ferrari M : Cancer nanotechnology: opportunities and challenges.Nat. Rev. Cancer5, 161–171 (2005).
- Li S-D , Huang L: Pharmacokinetics and biodistribution of nanoparticles. Mol. Pharmac.5, 496–504 (2008).
- Alexis F , PridgenE, MolnarLK, FarokhzadOC: Factors affecting the clearance and biodistribution of polymeric nanoparticles.Mol. Pharm.5, 505–515 (2008).
- De Jong WH , HagensWI, KrystekP, BurgerMC, SipsAJAM, GeertsmaRE: Particle size dependent organ distribution of gold nanoparticles after intravenous administration.Biomaterials29, 1912–1919 (2008).
- Demoy M , GibaudS, AndreuxJP, WeingartenC, GouritinB, CouvreurP: Splenic trapping of nanoparticles: complementary approaches for in situ studies.Pharm. Res.14, 463–468 (1997).
- Gibaud S , DemoyM, AndreuxJP, WeingartenC, GouritinB, CouvreurP: Cells involved in the capture of nanoparticles in hematopoietic organs.J. Pharm. Sci.85, 944–950 (1996).
- Lenaerts V , NagelkerkeJF, Van Berkel TJ et al.: In vivo uptake of polyisobutyl cyanoacrylate nanopartuicles by rat liver Kupffer, endothelial, and parenchyma cells. J. Pharm. Sci.73, 980–982 (1984).
- Moghimi SM , HunterAC, MurrayJC: Long circulating and target specific nanoparticles: theory and practice.Pharmacol. Rev.53, 283–318 (2001).
- Sadauskas E , WallinH, StoltenbergMet al.: Kupffer cells are central in the removal of nanoparticles from the organism.Part Fibre Toxicol.4, 10 (2007).
- Weissenbrock A , WirthM, GaborF: WGA grafted PLGA-nanospheres: preparation and association with Caco-2 cells.J. Control. Release99, 383–392 (2004).
- Nobs L , BucheggerF, GurnyR, AllémannE: Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin™ for active targeting.Eur. J. Pharm. Biopharm.58, 483–490 (2004).
- Prinzen L , MiserusR, DirksenAet al.: Optical and magnetic resonance imaging of cell death and platelet activation using annexin A5-functionalized quantum dots.Nano. Lett.7, 93–100 (2007).
- Niidome T , YamagataM, OkamotoYet al.: PEG-modified gold nanorods with a stealth character for in vivo application.J. Control. Release114, 343–347 (2006).
- Akiyama Y , MoriT, KatayamaY, NiidomeT: The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor bearing mice.J. Control. Release139, 81–84 (2009).
- Von Maltzahn G , Park J-H, Agrawal A et al.: Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res.69, 3892–3900 (2009).
- Eghtedari M , LiopoAV, CoplandJA, OraevskyAA, MotamediM: Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells.Nano. Lett.9, 287–291 (2009).
- Balogh L , NigavekarSS, NairBMet al.: Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models.Nanomedicine3, 281–296 (2007).
- Semmler-Behnke M , KreylingWG, LipkaJet al.: Biodistribution of 1.4- and 18-nm gold particles in rats.Small4, 2108–2111 (2008).
- Lin AWH , LewinskiNA, WestJL, HalasNJ, DrezekRA: Optically tunable nanoparticle contrast agents for early cancer detection: model-based analysis of gold nanoshells.J. Biomed. Opt.10, 064035 (2005).
- Perez-Juste J , Pastoriza-SantosI, Liz-MarzanL, MulvaneyP: Gold nanorods: synthesis, characterization and applications.Coord. Chem. Rev.249, 1870–1901 (2005).
- Sokolov K , FollenM, AaronJet al.: Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles.Cancer Res.63, 1999–2004 (2003).
- Stuart DA , HaesAJ, YonzonCR, HicksEM, Van Duyne RP: Biological applications of localised surface plasmonic phenomenae. IEE Proc. Nanobiotechnol.152, 13–32 (2005).
- Nikoobakht B , El-SayedMA: Preparation and growth mechanism of gold nanorods (NRs) using seed-mediated growth method.Chem. Mater.15, 1957–1962 (2003).
- Liu M , Guyot-SionnestP: Mechanism of silver(I)-assisted growth of gold nanorods and bipyramids.J. Physic. Chem. B109, 22192–22200 (2005).
- Takahashi H , NiidomeY, NiidomeT, KanekoK, KawasakiH, YamadaS: Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity.Langmuir22, 2–5 (2006).
- Alkilany AM , NagariaPK, HexelCR, ShawTJ, MurphyCJ, WyattMD: Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects.Small5, 701–708 (2009).
- Rayavarapu RG , PetersenW, HartsuikerLet al.: In vitro toxicity studies of polymer-coated gold nanorods.Nanotechnology21, No. 145101 (2010)
- Aggarwal P , HallJB, McLelandCB, DobrovolskaiaMA, McNeilSE: Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.Adv. Drug Del. Rev.61, 428–437 (2009).
- Dobrovolskaia MA , PatriAK, ZhengJet al.: Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.Nanomedicine5, 106–117 (2009).
- De Paoli Lacerda SH , ParkJJ, MeuseCet al.: Interaction of gold nanoparticles with common human blood proteins.ACS Nano.4, 365–379 (2010).
- Lynch I , CedervallT, LundqvistM, Cabaleiro-LagoC, LinseS, DawsonKA: The nanoparticle–protein complex as a biological entity; a complex fluids and surface science challenge for the 21st Century.Adv. Colloid Interface Sci.134–135, 167–174 (2007).
- Lynch I , DawsonKA: Protein–nanoparticle interactions.Nano. Today3, 40–47 (2008).
- Nel AE , MädlerL, VelegolDet al.: Understanding biophysicochemical interactions at the nano-bio interface.Nat. Mater.8, 543–557 (2009).
- Liao H , HafnerJH: Gold nanorod bioconjugates.Chem. Mater.17, 4636–4641 (2005).
- Storm G , BelliotSO, DaemenT, LasicDD: Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system.Adv. Drug Del. Rev.17, 31–48 (1995).
- Gref R , LückM, QuellecPet al.: ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.Colloids Surf. B: Biointerfaces18, 301–313 (2000).
- Owens III DE, Peppas NA: Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm.307, 93–102 (2006).
- Moghimi SM : Mechanisms of splenic clearance of blood cells and particles: towards development of new splenotropic agents.Adv. Drug Del. Rev.17, 103–115 (1995).
- Sadauskas E , DanscherG, StoltenbergM, VogelU, LarsenA, WallinH: Protracted elimination of gold nanoparticles from mouse liver.Nanomedicine5, 162–169 (2009).
- Yu LE , Yung L-YL, Ong C-N et al.: Translocation and effects of gold nanoparticles after inhalation exposure in rats. Nanotoxicology1, 235–242 (2007).
- Xia T , KovonichM, LiongMet al.: Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress.ACS Nano.2, 2121–21334 (2008).
- Nemmar A , HoetPH, VanquickenborneBet al.: Passage of inhaled particles into the blood circulation in humans.Circulation105, 411–414 (2002).
- Kreyling WG , SemmlerM, MollerW: Dosimetry and toxicology of ultrafine particles.J. Aerosol Med.17, 140–152 (2004).
- Mills NL , AminN, RobinsonSDet al.: Do inhaled carbon nanoparticles translocate directly into the circulation in humans?Am. J. Respir. Crit. Care Med.173, 426–431 (2006).